FDA Approved: CHILDRENS XYZAL ALLERGY — Supplemental Application (Chattem, Inc.)

View source ↗

Summary

FDA approved a supplemental labeling application for Children's XYZAL Allergy (levocetirizine dihydrochloride) by Chattem, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Urticaria

Drugs mentioned

• CHILDRENS XYZAL ALLERGY (LEVOCETIRIZINE DIHYDROCHLORIDE)

Snippet

SUPPL AP for CHILDRENS XYZAL ALLERGY (LEVOCETIRIZINE DIHYDROCHLORIDE)